|
    ABL Germany: Xetra

    Abbott Laboratories

    ABLXE
    Closed
    Back To Top
    Last Updated: Jul 26, 2021 6:30 p.m. CEDT Delayed quote

    100.90

    -1.35 -1.32%
    Previous Close
    €102.25
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 1.71K 65 Day Avg: 1.11K
    153% vs Avg
    100.90 Day Range 102.65
    83.74 52 Week Range 107.12

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABL Overview

    Performance

    5 Day
    • 0.05%
    1 Month
    • 5.85%
    3 Month
    • -0.15%
    YTD
    • 13.75%
    1 Year
    • 19.38%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 23 Full Ratings

    Recent News

    • eLesor
    • Dow Jones

    No Headlines Available

    • Other News
    • Press Releases

    No Headlines Available

    Abbott Laboratories

    Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

    Competitors

    Name Chg % Market Cap
    Novo Nordisk A/S ADR 1.70% €137.8B
    Nanologica AB 0.36% kr390.51M
    Novartis AG 0.14%
    Nile Pharmaceutical & Chemical Industries 1.25% ج.م.‏345.26M
    Competitor Data Provided ByCapital Cube Logo